# Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

> **NCT00780806** · PHASE1,PHASE2 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **BIOLOGICAL:** meningococcal B rLP2086 vaccine candidate
- **PROCEDURE:** Blood draw

## Key facts

- **NCT ID:** NCT00780806
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780806, "Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00780806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*